Literature DB >> 14593119

Epidermal growth factor receptor activation differentially regulates claudin expression and enhances transepithelial resistance in Madin-Darby canine kidney cells.

Amar B Singh1, Raymond C Harris.   

Abstract

Tight junctions (TJs) are the most apical cell-cell junctions, and claudins, the recently identified TJ proteins, are critical for maintaining cell-cell adhesion in epithelial cell sheets. Based on their in vivo distribution and the results of overexpression studies, certain claudins, including claudin-1 and -4, are postulated to increase, whereas other claudins, especially claudin-2, are postulated to decrease the overall transcellular resistance. The overall ratio among claudins expressed in a cell/tissue has been hypothesized to define the complexity of TJs. Disruption of the TJs contributes to various human diseases, and a correlation between reduction of TJ function and tumor dedifferentiation has been postulated. The epidermal growth factor (EGF) receptor (EGFR) is overexpressed in a wide spectrum of epithelial cancers, and its expression correlates with a more metastatic cancer phenotype. However, normal functioning of EGFR is essential for normal epithelial cell proliferation and differentiation. The role of EGFR-dependent signaling in the development and maintenance of epithelial TJ integrity has not been studied in detail. This study demonstrates that, in polarized Madin-Darby canine kidney II cells, EGF-induced EGFR activation significantly inhibited claudin-2 expression while simultaneously inducing cellular redistribution and increased expression of claudin-1, -3, and -4. Accompanying these EGF-induced changes in claudin expression was a 3-fold increase in transepithelial resistance, a functional measure of TJs. In contrast, there were no alterations in protein expression and/or intracellular localization of other TJ-related proteins (ZO-1 and occludin) or adherens junction-associated proteins (E-cadherin and beta-catenin), suggesting that EGF regulates TJ function through selective and differential regulation of claudins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14593119     DOI: 10.1074/jbc.M308682200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  72 in total

1.  Claudins 10 and 18 are predominantly expressed in lung adenocarcinomas and in tumors of nonsmokers.

Authors:  Heta Merikallio; Paavo Pääkkö; Terttu Harju; Ylermi Soini
Journal:  Int J Clin Exp Pathol       Date:  2011-09-27

2.  EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy.

Authors:  Joachim Lupberger; Mirjam B Zeisel; Fei Xiao; Christine Thumann; Isabel Fofana; Laetitia Zona; Christopher Davis; Christopher J Mee; Marine Turek; Sebastian Gorke; Cathy Royer; Benoit Fischer; Muhammad N Zahid; Dimitri Lavillette; Judith Fresquet; François-Loïc Cosset; S Michael Rothenberg; Thomas Pietschmann; Arvind H Patel; Patrick Pessaux; Michel Doffoël; Wolfgang Raffelsberger; Olivier Poch; Jane A McKeating; Laurent Brino; Thomas F Baumert
Journal:  Nat Med       Date:  2011-04-24       Impact factor: 53.440

Review 3.  Tight junctions in lung cancer and lung metastasis: a review.

Authors:  Ylermi Soini
Journal:  Int J Clin Exp Pathol       Date:  2012-02-12

4.  Paracellular Cl- permeability is regulated by WNK4 kinase: insight into normal physiology and hypertension.

Authors:  Kristopher T Kahle; Gordon G Macgregor; Frederick H Wilson; Alfred N Van Hoek; Dennis Brown; Thomas Ardito; Michael Kashgarian; Gerhard Giebisch; Steven C Hebert; Emile L Boulpaep; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-01       Impact factor: 11.205

5.  Hepatocyte growth factor stimulates the migration of gastric epithelial cells by altering the subcellular localization of the tight junction protein ZO-1.

Authors:  Yuichiro Nasu; Akio Ido; Shirou Tanoue; Shinichi Hashimoto; Fumisato Sasaki; Shuji Kanmura; Hitoshi Setoyama; Masatsugu Numata; Keita Funakawa; Akihiro Moriuchi; Hiroshi Fujita; Toshio Sakiyama; Hirofumi Uto; Makoto Oketani; Hirohito Tsubouchi
Journal:  J Gastroenterol       Date:  2012-06-22       Impact factor: 7.527

6.  Ras mutation impairs epithelial barrier function to a wide range of nonelectrolytes.

Authors:  James M Mullin; James M Leatherman; Mary Carmen Valenzano; Erika Rendon Huerta; Jon Verrechio; David M Smith; Karen Snetselaar; Mantao Liu; Mary Kay Francis; Christian Sell
Journal:  Mol Biol Cell       Date:  2005-09-21       Impact factor: 4.138

7.  Claudin expression in Barrett's esophagus and adenocarcinoma.

Authors:  Hajnalka Gyõrffy; Agnes Holczbauer; Pál Nagy; Zsuzsa Szabó; Péter Kupcsulik; Csilla Páska; János Papp; Zsuzsa Schaff; András Kiss
Journal:  Virchows Arch       Date:  2005-08-30       Impact factor: 4.064

8.  Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer.

Authors:  Punita Dhawan; Amar B Singh; Natasha G Deane; Yiran No; Sheng-Ru Shiou; Carl Schmidt; John Neff; M Kay Washington; R Daniel Beauchamp
Journal:  J Clin Invest       Date:  2005-06-16       Impact factor: 14.808

9.  Cingulin regulates claudin-2 expression and cell proliferation through the small GTPase RhoA.

Authors:  Laurent Guillemot; Sandra Citi
Journal:  Mol Biol Cell       Date:  2006-05-24       Impact factor: 4.138

10.  Claudin-4 augments alveolar epithelial barrier function and is induced in acute lung injury.

Authors:  Charlie Wray; Ying Mao; Jue Pan; Anita Chandrasena; Frank Piasta; James A Frank
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-15       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.